GLP-1R activation of neuroprotective pathways in neurons, microglia and astrocytes has also been reported: improvements in overall cognition, learning and motor function potentially associated with GLP-1RA administration in Alzheimers disease and Parkinsons disease may be mediated not only by their amyloid pathology-ameliorating properties (A, tau and -synuclein), but also the suppression of Ca 2+ deregulation and endoplasmic reticulum stress, anti-inflammatory activity, blockage of oxidative stress, mitochondrial dysfunction and apoptosis pathways, enhancements in the neuronal insulin sensitivity and energy metabolism, functional improvements in autophagy and mitophagy, elevated brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis, and neurogenesis 36
Because histamine triggers massive glutamate release in the brain, MCAS patients often suffer from severe anxiety and insomnia
Recently, glutamine was suggested to reduce the intestinal catabolism of amino acids, which may improve their bioavailability in the systemic circulation [29]
They are not shortcuts they are medical tools that, when used correctly, can produce life-changing results
Solubility: Highly soluble due to cationic residues